Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience. - Wikidata - wikimedia - TriplyDB

Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience.

Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience.

http://www.wikidata.org/entity/Q37126593

about

Advancement in high dose therapy and autologous stem cell rescue in lymphoma National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms Brentuximab vedotin in pretreated Hodgkin lymphoma patients: a systematic review and meta-analysis.LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy.Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway.Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4.Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.

P2860

Q26795538-5AD6DF0B-A2E7-4A40-8C13-8C7FB794C483 Q29248394-B82D255D-73B2-4F62-A10C-F6463B2EBFA1 Q38812806-2FEE5825-8B71-46F1-90FD-C4A11C6FAAB2 Q41001500-FD793F13-0798-4238-99D5-8E49026AE18C Q42847716-6ED65DC0-13E5-49E9-B81B-B60D792AA892 Q43269281-C0777C2C-73BD-4EFF-9AC2-94242E09EEF7 Q45989594-7ADCDFD4-560D-4AB2-B044-3DFF741EF565

P2860

Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience.

http://www.wikidata.org/entity/Q37126593

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic factors and long-te ...... a: a single-center experience.

@en

Prognostic factors and long-te ...... a: a single-center experience.

@nl

type

label

Prognostic factors and long-te ...... a: a single-center experience.

@en

Prognostic factors and long-te ...... a: a single-center experience.

@nl

prefLabel

Prognostic factors and long-te ...... a: a single-center experience.

@en

Prognostic factors and long-te ...... a: a single-center experience.

@nl

P1433

Q37126593-04C5F51D-4857-444F-A78D-F294237CDC2F

P1476

Q37126593-91B98138-CFFB-44F4-AB1C-02DB1E6B0A59

P2093

Q37126593-07EFA6F7-A178-4483-BD6B-B5485518DC78

Q37126593-44554D2A-0CB4-4574-93EF-6802AD173F1D

Q37126593-458CEA3C-C3B7-4EBC-946D-265A65F18F93

Q37126593-52C83703-E5EB-47FC-9A53-08E65650BC53

Q37126593-79FB6E27-BC8E-4044-AB26-C38C74F4FA26

Q37126593-851D688E-C0D4-4061-BCAF-9E2D5855958C

Q37126593-861830D7-694C-4A06-AD67-498FBEACFECE

Q37126593-91CCFBF4-63E2-4D1A-960C-7554572CDBEB

Q37126593-B4FD1E40-02F7-4208-A6D9-3B84E9FE53F2

Q37126593-C4C21186-4742-45B2-B1B2-FCF9F92F3EB1

P2860

Q37126593-0ABF93ED-B3BB-41C1-9FB5-563F7382F3E3

Q37126593-0AF02274-C386-4768-B3BD-D46FFB434779

Q37126593-14887DB5-334B-4CD3-ACA7-5D30EA3BC2CE

Q37126593-14DA5991-2BF8-4644-BFDA-6B21F7AD93B7

Q37126593-18772FE1-991F-4E21-80D7-7C66692EE46A

Q37126593-2029EF9B-4FF3-4207-8B20-1E3C04CCE6F8

Q37126593-2ABEAC49-7236-4AC8-99BB-7F5F07CDB9C8

Q37126593-32B559F0-BAE9-4A6F-BAA5-CC31330322A8

Q37126593-340F67BE-2026-486D-8CE8-B60B1274F41F

Q37126593-3F9B0197-6D2C-476A-89AA-81215D242FED

P2888

Q37126593-C2ED09B5-8DE9-4203-AAE4-CCDC3B8A1673

P304

Q37126593-02362F2D-12F3-4514-8B77-472ED67DC8FA

P31

Q37126593-3036FBB8-0810-44A1-89EA-F87351085B7E

P356

Q37126593-B0F1CA22-93C9-4003-87EA-A629C176E883

P433

Q37126593-C73B58CE-F883-4915-A41A-351EB752FD98

P478

Q37126593-62795FE2-ACBE-4D2C-93CE-D0768B03288C

P577

Q37126593-BF8512BA-FF4C-45CB-AD14-6E52AD33F66C

P5875

Q37126593-22B9362A-B6EB-4D5A-9A40-1FF8410DF6F7

P698

Q37126593-27033E75-F510-4EE9-8589-C0104E77B8EE

P932

Q37126593-F5DC2EB4-0D1B-49B8-85FE-339B92E95741

P356

S12032-013-0611-Y

P1433

Medical Oncology

P1476

Prognostic factors and long-te ...... a: a single-center experience.

@en

P2093

Adam Nowicki

http://www.w3.org/2001/XMLSchema#string

Anna Czyz

http://www.w3.org/2001/XMLSchema#string

Anna Lojko-Dankowska

http://www.w3.org/2001/XMLSchema#string

Dominik Dytfeld

http://www.w3.org/2001/XMLSchema#string

Ewa Bembnista

http://www.w3.org/2001/XMLSchema#string

Lidia Gil

http://www.w3.org/2001/XMLSchema#string

Maciej Kazmierczak

http://www.w3.org/2001/XMLSchema#string

Magdalena Matuszak

http://www.w3.org/2001/XMLSchema#string

Maria Kozlowska-Skrzypczak

http://www.w3.org/2001/XMLSchema#string

Mieczysław Komarnicki

http://www.w3.org/2001/XMLSchema#string

P2860

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.

Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma.

The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation.

Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma

Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy.

P2888

s12032-013-0611-y

P304

611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-013-0611-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236907724

http://www.w3.org/2001/XMLSchema#string

P698

23702734

http://www.w3.org/2001/XMLSchema#string

P932

3755217

http://www.w3.org/2001/XMLSchema#string